The modulation of B7.2 and B7.1 on B cells by immunosuppressive agents

Clinical and Experimental Immunology

Volumn 118, Issue 1, 1999, Pages 1-8

  Jirapongsananuruk, O ^a   Leung, Donald Y M ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Allergy; Costimulatory signals; Cyclosporin A; Dexamethasone

Indexed keywords

CYCLOSPORIN A; DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENT;

ALLERGY; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CROSS LINKING; DENDRITIC CELL; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; B-LYMPHOCYTES; BACTERIAL TOXINS; CELLS, CULTURED; CYCLOSPORINE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENTEROTOXINS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES, MONONUCLEAR; MALE; MEMBRANE GLYCOPROTEINS; SUPERANTIGENS;

EID: 0032869684     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.01028.x     Document Type: Article

References (46)

1. 1 Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14:233-58.
2. 2 Bluestone JA. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 1995; 2:555-9.
3. 3 Linsley PS, Greene JL, Brady W, Bajorath J, Ledbetter JA, Peach R. Human B7-1 (CD80) B 7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1994; 1:793-801.
4. 4 Ellis JH, Burden MN, Vinogradov DV, Linge C, Crowe JS. Interactions of CD80 and CD86 with CD28 and CTLA4. J Immunol 1996; 156:2700-9.
5. 5 Morton PA, Fu XT, Stewart JA et al. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2). J Immunol 1996; 156:1047-54.
6. 6 Kariv I, Truneh A, Sweet RW. Analysis of the site of interaction of CD28 with its counter-receptors CD80 and CD86 and correlation with function. J Immunol 1996; 157:29-38.
7. 7 Kuchroo VK, Das MP, Brown JA et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80:707-18.
8. 8 Freeman GJ, Boussiotis VA, Anumanthan A et al. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1995; 2:523-32.
9. 9 Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 1995; 154:97-105.
10. 10 Natesan M, Razi-Wolf Z, Reiser H. Costimulation of IL-4 production by murine B7-1 and B7-2 molecules. J Immunol 1996; 156:2783-91.
11. 11 Hofer MF, Jirapongsananuruk O, Trumble AE, Leung DYM. Upregulation of B7.2, but not B7.1, on B cells from patients with allergic asthma. J Allergy Clin Immunol 1998; 101:96-102.
12. 12 Jirapongsananuruk O, Hofer MF, Trumble AE, Norris DA, Leung DYM. Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis: a potential role in the modulation of IgE synthesis. J Immunol 1998; 160:4622-7.
13. 13 Blomster-Hautamaa DA, Schlievert PM. Preparation of toxic shock syndrome toxin-1. Methods Enzymol 1988; 165:37-43.
14. 14 Leung DYM, Gately M, Trumble A, Ferguson-Darnell B, Schlievert PM, Picker LJ. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production, J Exp Med 1995; 181:747-53.
15. 15 Yang Y, Wilson JM. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 1996; 273:1862-4.
16. 16 Keane-Myers AM, Gause WC, Finkelman FD, Xhou XD, Wills-Karp M. Development of murine allergic asthma is dependent upon B7-2 costimulation. J Immunol 1998; 160:1036-43.
17. 17 Nakada M, Nishizaki K, Yoshino T, Okano M, Masuda Y, Ohta N, Akagi T. CD86 (B7-2) antigen on B cells from atopic patients shows selective, antigen-specific upregulation. Allergy 1998; 53:527-31.
18. 18 Van Neerven RJ, Van de Pol MM, Van der Zee JS, Stiekema FE, De Boer M, Kapsenberg ML. Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression. Clin Exp Allergy 1998; 28:808-16.
19. 19 Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990; 248:705-11.
20. 20 Mourad W, Scholl P, Diaz A, Geha R, Chatila T. The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/ B cell interaction. J Exp Med 1989; 170:2011-22.
21. 21 Fraser JD, Newton ME, Weiss A. CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation. J Exp Med 1992; 175:1131-4.
22. 22 Goldbach-Mansky R, King PD, Taylor AP, Dupont B. A co-stimulatory role for CD28 in the activation of CD4+ T lymphocytes by staphylococcal enterotoxin B. Int Immunol 1992; 4:1351-60.
23. 23 Lando PA, Olsson C, Kalland T, Newton D, Kotb M, Dohlsten M. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II. J Immunol 1996; 157:2857-63.
24. 24 Saha B, Jaklic B, Harlan DM, Gray GS, June CH, Abe R. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig. J Immunol 1996; 157:3869-75.
25. 25 Heeg K, Wagner H. Induction of responsiveness in superantigen-induced anergic T cells. Role of ligand density and costimulatory signals. J Immunol 1995; 155:83-92.
26. 26 Muraille EM, De Becker G, Bakkus M, Thielemans K, Urbain J, Moser M, Leo O. Co-stimulation lowers the threshold for activation of naive T cells by bacterial superantigens. Int Immunol 1995; 7:295-304.
27. 27 Hofer MF, Harbeck RJ, Schlievert PM, Leung DYM. Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen. J Invest Dermatol 1999; 112:171-6.
28. 28 Muraille E, De Smedt T, Thielemans K, Urbain J, Moser M, Leo O. Activation of murine T cells by bacterial superantigens requires B7-mediated costimulation. Cell Immunol 1995; 162:315-20.
29. 29 Muraille E, De Smedt T, Urbain J, Moser M, Leo O. B7. 2 provides co-stimulatory functions in vivo in response to staphylococcal enterotoxin B. Eur J Immunol 1995; 25:2111-4.
30. 30 Berberich I, Shu GL, Clark EA. Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J Immunol 1994; 153:4357-66.
31. 31 Lalmanach-Girard AC, Chiles TC, Parker DC, Rothstein TL. T cell-dependent induction of NF-kappa B in B cells. J Exp Med 1993; 177:1215-9.
32. 32 Hsing Y, Hostager BS, Bishop GA. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes. J Immunol 1997; 159:4898-906.
33. 33 Francis DA, Karras JG, Ke XY, Sen R, Rothstein TL. Induction of the transcription factors NF-kappa B, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int Immunol 1995; 7:151-61.
34. 34 Yanagihara Y, Basaki Y, Ikizawa K, Kajiwara K. Possible role of nuclear factor-kappa B activity in germline C epsilon transcription in a human Burkitt lymphoma B cell line. Cell Immunol 1997; 176:66-74.
35. 35 Iciek LA, Delphin SA, Stavnezer J. CD40 cross-linking induces Ig epsilon germline transcripts in B cells via activation of NF-kappaB: synergy with IL-4 induction. J Immunol 1997; 158:4769-79.
36. 36 Choi MS, Brines RD, Holman MJ, Klaus GG. Induction of NF-AT in normal B lymphocytes by anti-immunoglobulin or CD40 ligand in conjunction with IL-4. Immunity 1994; 1:179-87.
37. 37 Mukaida N, Morita M, Ishikawa Y, Rice N, Okamoto S, Kasahara T, Matsushima K. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem 1994; 269: 13289-95.
38. 38 Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995; 270:286-90.
39. 39 Flanagan WM, Corthesy B, Bram RJ, Crabtree GR. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 1991; 352:803-7.
40. 40 Venkataraman C, Muthusamy N, Muthukkumar S, Bondada S. Activation of lyn, blk, and btk but not syk in CD72-stimulated B lymphocytes. J Immunol 1998; 160:3322-9.
41. 41 Newton JS, Li J, King ZQ, Schoendorf DE, Norton JD, Murphy JJ. B cell early response gene expression coupled to B cell receptor, CD40 and interleukin-4 receptor co-stimulation: evidence for a role of the egr-2/krox 20 transcription factor in B cell proliferation. Eur J Immunol 1996; 26:811-6.
42. 42 Dobbeling U. The effects of cyclosporin A on V(D)J recombination activity. Scand J Immunol 1997; 45:494-8.
43. 43 Guyre PM, Girard MT, Morganelli PM, Manganiello PD. Glucocorticoid effects on the production and actions of immune cytokines. J Steroid Biochem 1988; 30:89-93.
44. 44 Andersson J, Nagy S, Groth CG, Andersson U. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology 1992; 75:136-42.
45. 45 Fuleihan R, Ramesh N, Horner A et al. Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J Clin Invest 1994; 93:1315-20.
46. 46 Bischof F, Melms A. Glucocorticoids inhibit CD40 ligand expression of peripheral CD4+ lymphocytes. Cell Immunol 1998; 187:38-44.